Table 4 Between group differences in secluded patients
Nr 1 favoured product | Top 3 favoured products | |||||
|---|---|---|---|---|---|---|
Psychiatrist (n = 71) | Emergency physician (n = 37) | Fisher’s exact p | Psychiatrist (n = 71) | Emergency physician (n = 37) | Fisher’s exact p | |
Amisulpride | 0 (0) | 0 (0) | – | 1 (1.4) | 0 (0) | – |
Alprazolam | 0 (0) | 1 (2.7) | – | 2 (2.8) | 4 (10.8) | 0.178 |
Aripiprazole | 3 (4.2) | 1 (2.7) | 1.000 | 4 (5.6) | 1 (2.7) | 0.659 |
Bromazepam | 0 (0) | 0 (0) | – | 1 (1.4) | 0 (0) | – |
Clonazepam | 0 (0) | 0 (0) | – | 1 (1.4) | 1 (2.7) | 1.000 |
Cloxazolam | 0 (0) | 0 (0) | – | 1 (1.4) | 0 (0) | – |
Clorazepaat | 3 (4.2) | 1 (2.7) | 1.000 | 10 (14.1) | 7 (18.9) | 0.581 |
Clotiapine | 16 (22.5) | 7 (18.9) | 0.806 | 31 (43.7) | 16 (43.2) | 1.000 |
Diazepam | 0 (0) | 6 (16.2) | 0.001 | 6 (8.5) | 20 (54.1) | <0.001 |
Droperidol | 13 (18.3) | 3 (8.1) | 0.253 | 28 (39.4) | 11 (29.7) | 0.400 |
Escitalopram | 0 (0) | 0 (0) | – | 0 (0) | 0 (0) | – |
Haloperidol | 3 (4.2) | 1 (2.7) | 1.000 | 10 (14.1) | 14 (37.8) | .007 |
Lamotrigine | 0 (0) | 0 (0) | – | 0 (0) | 1 (2.7) | – |
Lorazepam | 6 (8.5) | 8 (21.6) | 0.071 | 38 (53.5) | 14 (37.8) | 0.156 |
Midazolam | 0 (0) | 2 (5.4) | 0.115 | 0 (0) | 7 (18.9) | <0.001 |
Olanzapine | 17 (23.9) | 6 (16.2) | 0.460 | 34 (47.9) | 9 (24.3) | 0.023 |
Prazepam | 0 (0) | 0 (0) | – | 1 (1.4) | 0 (0) | – |
Promethiazine | 0 (0) | 0 (0) | – | 1 (1.4) | 3 (8.1) | 0.115 |
Quetiapine | 3 (4.2) | 0 (0) | 0.550 | 12 (16.9) | 0 (0) | 0.007 |
Risperidone | 0 (0) | 0 (0) | – | 2 (2.8) | 1 (2.7) | 1.000 |
Zuclopenthixol | 0 (0) | 0 (0) | – | 4 (5.6) | 0 (0) | 0.297 |
Zuclopenthixol LA | 7 (9.9) | 0 (0) | 0.093 | 22 (31.0) | 0 (0) | <0.001 |
Sodium Valproate | 0 | 1 (2.7) | – | 2 (2.8) | 1 (2.7) | 1.000 |
Paliperidone | 0 | 0 | – | 1 (1.4) | 0 (0) | – |
Pipamperone | 0 | 0 | – | 1 (1.4) | 1 (2.7) | 1.000 |